New Report Provides Latest Data on Global Clinical Trials in AIDS-Related Cancer

Published Date : Aug 16, 2016

ALBANY, NY, Aug 16, 2016 has announced the addition of a new report, titled “AIDS - Related Cancer Global Clinical Trials Review, H1, 2016,” to its offering. This study presents an extensive understanding of the market and also includes an elaboration on the current and future competitive scenario in the market. The study also helps in making in-licensing and out-licensing strategies by providing a review on the key drugs being marketed in the market. This information on clinical trials taking place in the AIDS-related cancer global clinical trials market has been collated by consulting more than 80 clinical trial registries, journals, news, conferences, etc. from across the world.

A detailed reports on the key factors impacting the growth of the market for AIDS-related cancer global clinical trials has also been encapsulated in this study. It presents a comprehensive understanding of the landscape of the clinical trials by providing information on withdrawn, suspended, and terminated trials. The prime trends, key opportunities, and unmet needs in the market have also been presented through this study.

The first section of the report presents an overall view of the market and analyzes the different trials taking place in the market in terms of region. Similarly, the report also encapsulates an reports on the clinical trials based on trial status, phase, end points status, and country. In the following section of the study, the prime drugs utilized in in-progress trials have also been presented.

For Sample Copy, click here:

The report defines AIDS-related cancers and delivers information on their symptoms and causes. Individuals having AIDS are at a huge risk of developing other kinds of diseases and one amongst them is cancer. AIDS-related cancers are mainly of three types, namely cervical cancer, non- Hodgkin lymphoma, and Kaposi's sarcoma. For individuals suffering from HIV, these three types of cancers are called ‘AIDS-defining conditions’, meaning that in case an individual having HIV develops one of these cancers, it may point toward the development of AIDS.

Apart from these three common types of cancers linked with AIDS, there are also some other kinds of cancers that are less common in individuals having HIV. These are angiosarcoma, Hodgkin's lymphoma, colorectal cancer, anal cancer, cancers of the mouth, liver, lung, throat, testes, and various types of skin cancers such as squamous cell carcinoma, melanoma, and basal cell carcinoma.

Moving further, the chief five nations contributing in the clinical trials taking place in North America, Europe, Asia Pacific, and the Middle East and Africa have been presented. Furthermore, the prime companies taking part in AIDS-related cancer therapeutics clinical trials have also been presented in the last sections of this study.

To order report Call Toll Free: 866-997-4948 or send an email on